|
| 37679461 | In vivo deuterium magnetic resonance imaging of xenografted tumors following systemic administration of deuterated water. | Sci Rep | 2023 |
| 37679461 | In vivo deuterium magnetic resonance imaging of xenografted tumors following systemic administration of deuterated water. | Sci Rep | 2023 |
| 34688968 | Dynamical Systems Modeling of Early-Term Immune Reconstitution with Different Antithymocyte Globulin Administration Schedules in Allogeneic Stem Cell Transplantation. | Transplant Cell Ther | 2022 |
| 36248870 | Peripheral blood marker of residual acute leukemia after hematopoietic cell transplantation using multi-plex digital droplet PCR. | Front Immunol | 2022 |
| 35747850 | Determinants and Clinical Significance of Musculoskeletal Symptoms in Patients With Chronic Graft-Versus-Host Disease. | Hemasphere | 2022 |
| 35778600 | Chemokine receptor CCR9 suppresses the differentiation of CD4<sup>+</sup>CD8αα<sup>+</sup> intraepithelial T cells in the gut. | Mucosal Immunol | 2022 |
| 34688968 | Dynamical Systems Modeling of Early-Term Immune Reconstitution with Different Antithymocyte Globulin Administration Schedules in Allogeneic Stem Cell Transplantation. | Transplant Cell Ther | 2022 |
| 35021100 | In vivo availability of the cytokine IL-7 constrains the survival and homeostasis of peripheral iNKT cells. | Cell Rep | 2022 |
| 35158792 | Increased Activity of a NK-Specific CAR-NK Framework Targeting CD3 and CD5 for T-Cell Leukemias. | Cancers (Basel) | 2022 |
| 35114411 | Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis. | Transplant Cell Ther | 2022 |
| 34875023 | Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus. | Rheumatology (Oxford) | 2022 |
| 35778600 | Chemokine receptor CCR9 suppresses the differentiation of CD4<sup>+</sup>CD8αα<sup>+</sup> intraepithelial T cells in the gut. | Mucosal Immunol | 2022 |
| 35747850 | Determinants and Clinical Significance of Musculoskeletal Symptoms in Patients With Chronic Graft-Versus-Host Disease. | Hemasphere | 2022 |
| 36248870 | Peripheral blood marker of residual acute leukemia after hematopoietic cell transplantation using multi-plex digital droplet PCR. | Front Immunol | 2022 |
| 35158792 | Increased Activity of a NK-Specific CAR-NK Framework Targeting CD3 and CD5 for T-Cell Leukemias. | Cancers (Basel) | 2022 |
| 34875023 | Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus. | Rheumatology (Oxford) | 2022 |
| 35114411 | Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis. | Transplant Cell Ther | 2022 |
| 35021100 | In vivo availability of the cytokine IL-7 constrains the survival and homeostasis of peripheral iNKT cells. | Cell Rep | 2022 |
| 32785680 | Glycolytic metabolism of pathogenic T cells enables early detection of GVHD by 13C-MRI. | Blood | 2021 |
| 33633313 | Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemia. | Leukemia | 2021 |
| 34054809 | The Timing and Abundance of IL-2Rβ (CD122) Expression Control Thymic <i>i</i>NKT Cell Generation and NKT1 Subset Differentiation. | Front Immunol | 2021 |
| 32785680 | Glycolytic metabolism of pathogenic T cells enables early detection of GVHD by 13C-MRI. | Blood | 2021 |
| 33633313 | Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemia. | Leukemia | 2021 |
| 34054809 | The Timing and Abundance of IL-2Rβ (CD122) Expression Control Thymic <i>i</i>NKT Cell Generation and NKT1 Subset Differentiation. | Front Immunol | 2021 |
| 31493539 | Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases. | Biol Blood Marrow Transplant | 2020 |
| 31959992 | Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma. | Nat Med | 2020 |
| 32105293 | Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant: A Nonrandomized Clinical Trial. | JAMA Oncol | 2020 |
| 32393513 | The Abundance and Availability of Cytokine Receptor IL-2Rβ (CD122) Constrain the Lymphopenia-Induced Homeostatic Proliferation of Naive CD4 T Cells. | J Immunol | 2020 |
| 32275165 | <sup>90</sup>Y-Daclizumab (Anti-CD25), High-Dose Carmustine, Etoposide, Cytarabine, and Melphalan Chemotherapy and Autologous Hematopoietic Stem Cell Transplant Yielded Sustained Complete Remissions in 4 Patients with Recurrent Hodgkin's Lymphoma. | Cancer Biother Radiopharm | 2020 |
| 31493539 | Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases. | Biol Blood Marrow Transplant | 2020 |
| 31959992 | Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma. | Nat Med | 2020 |
| 32105293 | Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant: A Nonrandomized Clinical Trial. | JAMA Oncol | 2020 |
| 32393513 | The Abundance and Availability of Cytokine Receptor IL-2Rβ (CD122) Constrain the Lymphopenia-Induced Homeostatic Proliferation of Naive CD4 T Cells. | J Immunol | 2020 |
| 32275165 | <sup>90</sup>Y-Daclizumab (Anti-CD25), High-Dose Carmustine, Etoposide, Cytarabine, and Melphalan Chemotherapy and Autologous Hematopoietic Stem Cell Transplant Yielded Sustained Complete Remissions in 4 Patients with Recurrent Hodgkin's Lymphoma. | Cancer Biother Radiopharm | 2020 |
| 30342913 | Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution. | Biol Blood Marrow Transplant | 2019 |
| 30342913 | Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution. | Biol Blood Marrow Transplant | 2019 |
| 30089900 | Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patients. | Bone Marrow Transplant | 2019 |
| 30913039 | Post-transplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression. | J Clin Invest | 2019 |
| 30886618 | Differential Cytokine Utilization and Tissue Tropism Results in Distinct Repopulation Kinetics of Naïve vs. Memory T Cells in Mice. | Front Immunol | 2019 |
| 30089900 | Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patients. | Bone Marrow Transplant | 2019 |
| 30886618 | Differential Cytokine Utilization and Tissue Tropism Results in Distinct Repopulation Kinetics of Naïve vs. Memory T Cells in Mice. | Front Immunol | 2019 |
| 30913039 | Post-transplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression. | J Clin Invest | 2019 |
| 29248669 | Imaging of subclinical haemopoiesis after stem-cell transplantation in patients with haematological malignancies: a prospective pilot study. | Lancet Haematol | 2018 |
| 29248669 | Imaging of subclinical haemopoiesis after stem-cell transplantation in patients with haematological malignancies: a prospective pilot study. | Lancet Haematol | 2018 |
| 29812997 | T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma. | J Clin Oncol | 2018 |
| 29812997 | T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma. | J Clin Oncol | 2018 |
| 28797782 | Predictors for Permanent Discontinuation of Systemic Immunosuppression in Severely Affected Chronic Graft-Versus-Host Disease Patients. | Biol Blood Marrow Transplant | 2017 |
| 28552733 | FLT3 ligand regulates thymic precursor cells and hematopoietic stem cells through interactions with CXCR4 and the marrow niche. | Exp Hematol | 2017 |
| 28642474 | Comparing DNA enrichment of proliferating cells following administration of different stable isotopes of heavy water. | Sci Rep | 2017 |
| 28756593 | Serial changes in lymphocyte subsets in patients with newly diagnosed high grade astrocytomas treated with standard radiation and temozolomide. | J Neurooncol | 2017 |